耐药时代的耳念珠菌
Candida auris in the Age of Resistance.
作者信息
Oh Michael, Heyl Jonathan, Babu Benson A
机构信息
Medicine, Lake Erie College of Osteopathic Medicine, Auburndale, USA.
Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
出版信息
Cureus. 2020 Sep 9;12(9):e10334. doi: 10.7759/cureus.10334.
Abstract
( is an opportunistic ascomycetous budding yeast that has been emerging as an invasive, multidrug-resistant pathogen over the past 10 years since its discovery. This fungi is the first to be labeled as a public health threat according to the Centers for Disease Control (CDC) and has since become a major problem in the United States. This serves as a detailed overview of the various factors contributing to the pathogenicity of .
摘要
（是一种机会性子囊芽殖酵母，自发现以来的过去10年中已成为一种侵袭性、耐多药病原体。根据疾病控制中心（CDC）的说法，这种真菌是第一个被列为对公众健康构成威胁的真菌，此后在美国已成为一个主要问题。本文详细概述了导致其致病性的各种因素。 ）
你提供的原文开头括号里内容不完整，请确认一下原文信息是否准确。
相似文献
1
Candida auris in the Age of Resistance.耐药时代的耳念珠菌
Cureus. 2020 Sep 9;12(9):e10334. doi: 10.7759/cureus.10334.
2
Candida Auris Urinary Tract Infection in a Nursing Home Patient With Multicomorbidities.一名患有多种合并症的疗养院患者的耳念珠菌尿路感染
Cureus. 2020 Dec 27;12(12):e12322. doi: 10.7759/cureus.12322.
3
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species.新兴病原体耳念珠菌（Candida auris）英国分离株与其他关键致病性念珠菌种的比较致病性。
mSphere. 2016 Aug 18;1(4). doi: 10.1128/mSphere.00189-16. eCollection 2016 Jul-Aug.
4
The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.双组分应答调节子 Ssk1 和丝裂原活化蛋白激酶 Hog1 控制新型致病真菌耳念珠菌的抗真菌药物耐药性和细胞壁结构。
mSphere. 2020 Oct 14;5(5):e00973-20. doi: 10.1128/mSphere.00973-20.
5
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.鉴定耳念珠菌在大蜡螟感染模型中的差异致病性。
Microbiol Spectr. 2021 Sep 3;9(1):e0001321. doi: 10.1128/Spectrum.00013-21. Epub 2021 Jun 9.
6
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.调查美国 2013 年 5 月至 2016 年 8 月首例报告的 7 例耳念珠菌感染病例，这是一种全球新兴的侵袭性、多药耐药真菌。
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1234-1237. doi: 10.15585/mmwr.mm6544e1.
7
Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris.猪蛋白 1 调控新兴真菌病原体耳念珠菌的应激耐受和毒力。
mSphere. 2018 Oct 24;3(5):e00506-18. doi: 10.1128/mSphere.00506-18.
8
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.2013年5月至2016年8月美国对全球新出现的侵袭性、多重耐药真菌——耳念珠菌的前七例报告病例的调查。
Am J Transplant. 2017 Jan;17(1):296-299. doi: 10.1111/ajt.14121.
9
A rare fungus on the rise: .一种日益增多的罕见真菌：
Am J Health Syst Pharm. 2018 Jul 15;75(14):1013-1017. doi: 10.2146/ajhp170640. Epub 2018 Jun 12.
10
: An Overview of the Emerging Drug-Resistant Fungal Infection.新兴耐药真菌感染概述
Infect Chemother. 2022 Jun;54(2):236-246. doi: 10.3947/ic.2022.0008.
引用本文的文献
1
Evaluation of a high-throughput assay for use on the cobas 5800/6800/8800 omni Utility Channel.用于 cobas 5800/6800/8800 通用通道的高通量检测方法的评估
Microbiol Spectr. 2025 Jul;13(7):e0025425. doi: 10.1128/spectrum.00254-25. Epub 2025 May 16.
2
Severe infections in critically ill patients with COVID-19.新型冠状病毒肺炎危重症患者的严重感染
J Intensive Med. 2023 Sep 2;3(4):291-297. doi: 10.1016/j.jointm.2023.07.005. eCollection 2023 Oct 31.
3
High-throughput assay for effect screening of amphotericin B and bioactive components on filamentous Candida albicans.高通量筛选两性霉素 B 和生物活性成分对丝状白色念珠菌的作用。
J Appl Microbiol. 2022 Nov;133(5):3113-3125. doi: 10.1111/jam.15770. Epub 2022 Aug 18.
4
and other phylogenetically related species - a mini-review of the literature.以及其他系统发育相关物种——文献综述
Germs. 2021 Sep 29;11(3):441-448. doi: 10.18683/germs.2021.1281. eCollection 2021 Sep.
本文引用的文献
1
Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack.新型真菌病原体耳念珠菌能够逃避中性粒细胞的攻击。
mBio. 2018 Aug 21;9(4):e01403-18. doi: 10.1128/mBio.01403-18.
2
Candida auris: an Emerging Fungal Pathogen.耳念珠菌：一种新兴的真菌病原体。
J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.01588-17. Print 2018 Feb.
3
Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.《耳念珠菌（一种新兴的耐多药酵母）患者的调查和管理方法》
Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744.
4
Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017.实地记录：2016年6月至2017年5月美国医疗机构中耳念珠菌的持续传播
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):514-515. doi: 10.15585/mmwr.mm6619a7.
5
Candida auris candidaemia in Indian ICUs: analysis of risk factors.印度重症监护病房中的耳念珠菌血症：危险因素分析
J Antimicrob Chemother. 2017 Jun 1;72(6):1794-1801. doi: 10.1093/jac/dkx034.
6
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.2013年5月至2016年8月美国对全球新出现的侵袭性、多重耐药真菌——耳念珠菌的前七例报告病例的调查。
Am J Transplant. 2017 Jan;17(1):296-299. doi: 10.1111/ajt.14121.
7
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
8
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris.常见误诊的多重耐药病原体耳念珠菌的基因组草图
BMC Genomics. 2015 Sep 7;16(1):686. doi: 10.1186/s12864-015-1863-z.
9
Multidrug-resistant endemic clonal strain of Candida auris in India.印度耳念珠菌的多药耐药地方性克隆菌株。
Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):919-26. doi: 10.1007/s10096-013-2027-1. Epub 2013 Dec 20.
10
New clonal strain of Candida auris, Delhi, India.印度德里地区发现新型假丝酵母菌克隆株。
Emerg Infect Dis. 2013 Oct;19(10):1670-3. doi: 10.3201/eid1910.130393.
Zotero 插件